16 completed, 3 unknown, 1 active not recruiting, 1 terminated. 21 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 21 | Completed 16, Unknown 3, Active not recruiting 1, Terminated 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Hepatitis A: new trials by email Literature Review of Hepatitis A trials Research Report on Hepatitis A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV Inactivated hepatitis A vaccine (I-HAV) - Hepatitis A, Hepatitis A Virus | Phase 3 | Active not recruiting | Chiang Mai University | 36 | 2025-05-25 | 2026-05-22 |
| Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents Mevac-A vaccine, Havrix 720 Junior - HAV, Hepatitis A | Phase 3 | Completed | Chiang Mai University | 120 | 2024-04-27 | 2025-05-04 |
| To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24mons-15yrs Boryung Hepatitis A Vaccine Pre-Filled Syringe Inj. 0.5 mL, HAVRIX 720 Junior 0.5 mL - Hepatitis A, Hep A | Phase 3 | Unknown | Boryung Biopharma Co., Ltd. | 106 | 2022-12-01 | 2022-11-14 |
| Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine MenACWY-CRM, Combined inactivated hepatitis A & recombinant hepatitis B, Recombinant hepatitis B vaccine - Meningococcal Disease, Meningococcal Meningitis | Phase 3 | Completed | Novartis Vaccines | 252 | 2011-10-01 | 2017-06-08 |
| Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery Varicella Vaccine, Hepatitis A Vaccine - Varicella, Hepatitis A | Phase 2 / Phase 3 | Unknown | University of Sao Paulo General Hospital | 600 | 2009-06-01 | 2009-06-23 |
| Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines Japanese encephalitis vaccine, Japanese encephalitis vaccine (Acambis), Hepatitis A vaccine - Japanese Encephalitis, Hepatitis A | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 1200 | 2008-08-01 | 2015-04-21 |
| Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster Dose Hepatitis A vaccine AVAXIM 80U, Hepatitis A vaccine (HAVRIX 720) - Hepatitis A | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 720 | 2007-06-01 | 2014-01-22 |
| Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines Epaxal, Havrix 720 - Hepatitis A | Phase 3 | Completed | Crucell Holland BV | 327 | 2007-03-14 | 2019-04-08 |
| Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2 Twinrix, interleukin-2 - HIV Infections, Hepatitis A | Phase 3 | Unknown | Aalborg University Hospital | 80 | 2007-03-01 | 2007-11-01 |
| Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule Twinrix™ adult - Hepatitis B, Hepatitis A | Phase 3 | Completed | GlaxoSmithKline | 51 | 2004-11-01 | 2018-02-15 |
| Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults Twinrix™ - Hepatitis B, Hepatitis A | Phase 3 | Completed | GlaxoSmithKline | 50 | 2004-11-01 | 2018-08-17 |
| Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years Twinrix™ Adult, Twinrix™ Junior - Hepatitis B, Hepatitis A | Phase 3 | Completed | GlaxoSmithKline | 244 | 2004-05-01 | 2017-04-20 |
| Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule TWINRIX™ ADULT, Engerix TM - Hepatitis B, Hepatitis A | Phase 3 | Completed | GlaxoSmithKline | 178 | 2004-02-16 | 2018-08-20 |
| Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months Havrix™, Infanrix™, ActHIB™ - Hepatitis A | Phase 3 | Completed | GlaxoSmithKline | 468 | 2003-11-11 | 2018-08-20 |
| Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared Twinrix™ Adult, Twinrix™ Junior - Hepatitis B, Hepatitis A | Phase 3 | Completed | GlaxoSmithKline | 276 | 2003-11-01 | 2018-08-20 |
| Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children Havrix®, M-M-R®II, VARIVAX® - Hepatitis A | Phase 3 | Completed | GlaxoSmithKline | 1474 | 2003-10-06 | 2018-07-31 |
| Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age GSK Biologicals 2-dose inactivated hepatitis A vaccine (Havrix), Prevnar™ - Hepatitis A | Phase 3 | Completed | GlaxoSmithKline | 521 | 2003-09-11 | 2018-08-06 |
| Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine Combined Hepatitis A and B vaccine - Hepatitis B, Hepatitis A | Phase 3 | Completed | GlaxoSmithKline | 143 | 2003-09-01 | 2016-09-07 |
| Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients group1, group2 - HIV Infection | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 99 | 2003-06-01 | 2011-12-16 |
| Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity Combined Vi polysaccharide typhoid vaccine and hepatitis A vaccine- Hepatyrix - Hepatitis A | Phase 3 | Completed | GlaxoSmithKline | 1034 | 2002-05-01 | 2016-09-09 |
Showing 20 of 21. Sign in to see all of them.
Hepatitis B (8) · Hepatitis (3) · HIV Infections (2) · Vaccine-Preventable Diseases (2) · Chickenpox (1) · Encephalitis, Japanese (1) · Meningitis, Meningococcal (1) · Meningococcal Infections (1) · Typhoid Fever (1)
Digestive System Diseases (21) · Enterovirus Infections (21) · Hepatitis, Viral, Human (21) · Infections (21) · Liver Diseases (21) · Picornaviridae Infections (21) · RNA Virus Infections (21) · Virus Diseases (21) · Hepatitis (18) · Blood-Borne Infections (9) · Communicable Diseases (9) · DNA Virus Infections (9) · Hepadnaviridae Infections (8) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2)
Hepatitis A Vaccines (6) · Chickenpox Vaccine (2) · twinrix (2) · Diphtheria-Tetanus-acellular Pertussis Vaccines (1) · Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (1) · Hepatitis B Vaccines (1) · Heptavalent Pneumococcal Conjugate Vaccine (1) · Interleukin-2 (1) · Japanese Encephalitis Vaccines (1) · MenACWY-CRM vaccine (1) · epaxal berna (1)
GlaxoSmithKline (11) · Chiang Mai University (2) · Sanofi Pasteur, a Sanofi Company (2) · Aalborg University Hospital (1) · Assistance Publique - Hôpitaux de Paris (1) · Boryung Biopharma Co., Ltd. (1) · Crucell Holland BV (1) · Novartis Vaccines (1) · University of Sao Paulo General Hospital (1)
Belgium (5) · Thailand (4) · United States (3) · Australia (2) · Czechia (2) · Brazil (1) · China (1) · Denmark (1) · France (1) · Germany (1) · Israel (1) · Philippines (1) · Slovakia (1) · South Korea (1) · Spain (1)
Natchaya Kunanitthaworn, MD (2) · Tavitiya Sudjaritruk, MD, PhD (2) · Glacus S Brito, MD (1) · Henrik Nielsen, MD, DMSci (1) · Odile Launay, MD (1) · Ron Dagan, MD (1) · Shai Ashkenazi, MD (1)
PMID 22777096, PMID 24656175, PMID 25483566, PMID 26770041, PMID 27093164